Baird raised the firm’s price target on AptarGroup (ATR) to $185 from $170 and keeps an Outperform rating on the shares. The firm said AptarGroup is well-positioned to deliver a high-quality DD earnings growth algorithm, propagated by growth in Pharmaceuticals, cost-out initiatives in Packaging that should increase operating leverage as volumes eventually normalize, and capital allocation optionality inclusive of share buybacks.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATR:
